Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.5400

-0.0326 (-5.69%)

At close: Jun 12, 2026, 4:00 PM EDT

0.5611

+0.0211 (3.91%)

After-hours: Jun 12, 2026, 7:12 PM EDT

Citius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	15	22	91	109	177	296
Market Cap Growth	103.07%	-75.31%	-16.54%	-38.55%	-40.30%	412.69%
Enterprise Value	11.04	34.19	95.02	83.32	136.48	227.72
Last Close Price	0.54	1.24	12.52	17.11	30.25	50.75
PB Ratio	0.20	0.33	1.29	1.20	1.72	2.24
Debt / Equity Ratio	0.01	0.02	0.00	0.00	0.00	0.01
Net Debt / Equity Ratio	0.01	0.03	0.00	-0.29	-0.40	-0.52
Net Debt / EBITDA Ratio	-0.01	-0.05	-0.01	0.71	1.24	2.96
Net Debt / FCF Ratio	-0.03	-0.07	-0.01	0.90	1.45	2.85
Inventory Turnover	0.05	0	0	-	-	-
Quick Ratio	0.02	0	0	4.58	9.21	17.60
Current Ratio	0.49	0.53	0.31	5.95	9.84	18.28
Return on Equity (ROE)	-68.23%	-52.42%	-47.63%	-33.40%	-28.48%	-27.70%
Return on Assets (ROA)	-43.26%	-31.97%	-38.70%	-34.37%	-26.44%	-25.28%
Return on Invested Capital (ROIC)	-46.70%	-29.83%	-41.40%	-52.97%	-48.62%	-47.10%
Return on Capital Employed (ROCE)	-65.04%	-46.18%	-47.01%	-35.44%	-26.88%	-26.42%
Buyback Yield / Dilution	-138.25%	-64.49%	-11.16%	-3.57%	-34.52%	-177.28%
Total Shareholder Return	-138.25%	-64.49%	-11.16%	-3.57%	-34.52%	-177.28%

SEC Filings: 10-K · 10-Q